Robocath

Recent Finacing

Series C

Recent Raise

$43.4M

Robocath designs, develops and commercializes robotic platforms for interventional cardiology; R‑One enables seated, remote-controlled coronary angioplasty with cath-lab compatibility, instrument-control technologies R‑grasp and SecurAccess, and development toward neurovascular applications.